The loss of c-Jun N-Terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo

dc.contributor.authorMazzitelli, Sonia
dc.contributor.authorXu, Ping
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorDavis, Roger J.
dc.contributor.authorTournier, Cathy
dc.date.accessioned2019-10-04T16:29:46Z
dc.date.available2019-10-04T16:29:46Z
dc.date.issued2011-11-23
dc.date.updated2019-10-04T16:29:46Z
dc.description.abstractPhosphorylation plays a central role in the dynamic regulation of the processing of the amyloid precursor protein (APP) and the production of amyloid-β (Aβ), one of the clinically most important factors that determine the onset of Alzheimer's disease (AD). This has led to the hypothesis that aberrant Aβ production associated with AD results from regulatory defects in signal transduction. However, conflicting findings have raised a debate over the identity of the signaling pathway that controls APP metabolism. Here, we demonstrate that activation of the c-Jun N-terminal protein kinase (JNK) is essential for mediating the apoptotic response of neurons to Aβ. Furthermore, we discovered that the functional loss of JNK signaling in neurons significantly decreased the number of amyloid plaques present in the brain of mice carrying familial AD-linked mutant genes. This correlated with a reduction in Aβ production. Biochemical analyses indicate that the phosphorylation of APP at threonine 668 by JNK is required for γ-mediated cleavage of the C-terminal fragment of APP produced by β-secretase. Overall, this study provides genetic evidence that JNK signaling is required for the formation of amyloid plaques in vivo. Therefore, inhibition of increased JNK activity associated with aging or with a pathological condition constitutes a potential strategy for the treatment of AD.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec689484
dc.identifier.issn0270-6474
dc.identifier.pmid22114267
dc.identifier.urihttps://hdl.handle.net/2445/141737
dc.language.isoeng
dc.publisherThe Society for Neuroscience
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1523/JNEUROSCI.4491-11.2011
dc.relation.ispartofJournal of Neuroscience, 2011, vol. 31, num. 47, p. 16969-16976
dc.relation.urihttps://doi.org/10.1523/JNEUROSCI.4491-11.2011
dc.rightscc-by-nc-sa (c) Mazzitelli, Sonia et al., 2011
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationAntihormones
dc.subject.classificationAmiloïdosi
dc.subject.classificationProteïnes quinases
dc.subject.classificationGenètica
dc.subject.classificationRatolins (Animals de laboratori)
dc.subject.otherHormone antagonists
dc.subject.otherAmyloidosis
dc.subject.otherProtein kinases
dc.subject.otherGenetics
dc.subject.otherMice (Laboratory animals)
dc.titleThe loss of c-Jun N-Terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
689484.pdf
Mida:
1.34 MB
Format:
Adobe Portable Document Format